Eisai
4523.T
#2171
Rank
NZ$14.72 B
Marketcap
NZ$52.23
Share price
2.53%
Change (1 day)
5.60%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.48. an increase over its 2024 EPS that were of NZ$1.67.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8611.85%
2024NZ$1.67-32.63%
2023NZ$2.475.52%
2022NZ$2.34-74.01%
2021NZ$9.02-66.58%
2020NZ$26.9998.24%
2019NZ$13.6117.01%
2018NZ$11.6437.78%
2017NZ$8.44-27.62%
2016NZ$11.6735.33%
2015NZ$8.62-2.82%
2014NZ$8.87-27.66%
2013NZ$12.27-27.49%
2012NZ$16.92-12.67%
2011NZ$19.3788.08%
2010NZ$10.30-11.06%
2009NZ$11.58-390.15%
2008NZ-$3.99-127.78%
2007NZ$14.3711.78%
2006NZ$12.864.38%
2005NZ$12.327.4%
2004NZ$11.4743.03%
2003NZ$8.0225.09%
2002NZ$6.4152.67%
2001NZ$4.2069.76%
2000NZ$2.47